Canada High Court To Hear Teva's Viagra Patent Appeal

Law360, New York (May 6, 2011, 7:14 PM EDT) -- The Supreme Court of Canada said Thursday it would hear Teva Canada Ltd.’s challenge to Pfizer Inc.’s patent for Viagra, in the latest bid by a Canadian drug maker to secure the right to produce a generic version of the erectile dysfunction drug.

The high court granted Teva Canada’s leave to appeal without comment Thursday, agreeing to review a September 2010 ruling from Canada’s Federal Court of Appeal that Teva Canada could not produce a generic version of Viagra until Pfizer’s Canadian patent expired in May...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.